col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


24 Ergebisse       Seite 1

 [1] 
Elsevier: Toxicology Reports
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Nov―22 Targeting mutation sites in the Omicron Variant of SARS-CoV-2 as Potential Therapeutic Strategy against COVID-19 by Antiretroviral Drugs Ochuko L. Erukainure, Aliyu Muhammad, Rahul Ravichandran, Musa M. Abarshi, Sanusi B. Katsayal, Murtala B. Abubakar, et al. (+4)
2 [GO] 2024―Feb―22 Liver enzymes as a predictor of mortality in patients with COVID-19? A cross-sectional study Mansour Abbasi, Babak Choobi Anzali, Hamid Reza Mehryar
3 [GO] 2023―Okt―17 Relationship between Serum Lactate Dehydrogenase Levels and Prognosis in Patients Infected with Omicron and Delta Variants of COVID-19: A cross-sectional study Fatemeh Ostadi, Babak Choobi Anzali, Hamid Reza Mehryar
4 [GO] 2022―Mai―06 Retraction notice to “Why are we vaccinating children against COVID-19?” [Toxicol. Rep. 8 (2021) 1665-1684] Ronald N. Kostoff, Daniela Calina, Darja Kanduc, Michael B. Briggs, Panayiotis Vlachoyiannopoulos, Andrey A. Svistunov, Aristidis Tsatsakis
5 [GO] 2022―Mai―02 Retraction notice to “Use of ivermectin in the treatment of Covid-19: A pilot trial” [Toxicol. Rep. 8 (2021) 505-510] Henrique Pott-Junior, Mônica Maria Bastos Paoliello, Alice de Queiroz Constantino Miguel, Anderson Ferreira da Cunha, Caio Cesar de Melo Freire, Fábio Fernandes Neves, et al. (+4)
6 [GO] 2022―Mrz―29 Egyptian perspectives on potential risk of paracetamol/acetaminophen-induced toxicities: Lessons learnt during COVID-19 pandemic Enas M.A. Mostafa, Ayat M. Tawfik, Khadiga M. Abd-Elrahman
7 [GO] 2021―Dez―17 Expression of concern: Why are we vaccinating children against COVID-19?
8 [GO] 2021―Dez―16 Impact of COVID-19 Acute Respiratory Disease on the Risk Factors Attributed to Cancer Patients Elena Lak, Mohammad Javad Mohammadi, Homayoun Yousefi
9 [GO] 2021―Nov―26 PFOA induces alteration in DNA methylation regulators and SARS-CoV-2 targets Ace2 and Tmprss2 in mouse lung tissues Saeed Ahmad, Yi Wen, Joseph Maria Kumar Irudayaraj
10 [GO] 2021―Okt―09 Erratum to “Why are we vaccinating children against COVID-19?” [Toxicol. Rep. 8C (2021) 1665-1684 / 1193] Ronald N. Kostoff, Daniela Calina, Darja Kanduc, Michael B. Briggs, Panayiotis Vlachoyiannopoulos, Andrey A. Svistunov, Aristidis Tsatsakis
11 [GO] 2021―Sep―14 Why are We Vaccinating Children against COVID-19? Ronald N. Kostoff, Daniela Calina, Darja Kanduc, Michael B. Briggs, Panayiotis Vlachoyiannopoulos, Andrey A. Svistunov, Aristidis Tsatsakis
12 [GO] 2021―Sep―02 Erratum to “Safety of COVID-19 vaccines administered in the EU: Should we be concerned?” [Toxicol. Rep. 8C (2021) 871-879/1111] Antonio F. Hernández, Daniela Calina, Konstantinos Poulas, Anca Oana Docea, Aristidis M. Tsatsakis
13 [GO] 2021―Sep―02 Erratum to “COVID-19 pandemic and alcohol consumption: Impacts and interconnections” [Toxicol. Rep. 8C (2021) 529 - 535/1078] Daniela Calina, Thomas Hartung, Ileana Mardare, Mihaela Mitroi, Konstantinos Poulas, Aristidis Tsatsakis, et al. (+2)
14 [GO] 2021―Aug―31 Common contributing factors to COVID-19 and inflammatory bowel disease Ronald Neil Kostoff, Michael Brandon Briggs, Darja Kanduc, Darla Roye Shores, Leda Kovatsi, Alexander I. Vardavas, Alan L. Porter
15 [GO] 2021―Aug―05 Risk factors associated with COVID-19-induced death in patients hospitalized in intensive care units (ICUs) in a city in Southern Brazil André S. Olak, Aline M. Susuki, Milena Kanashiro, Monica M.B. Paoliello, Michael Aschner, Mariana R. Urbano
16 [GO] 2021―Jul―08 Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage Athanasios Chalkias, Ioannis Pantazopoulos, Nikolaos Papagiannakis, Anargyros Skoulakis, Eleni Laou, Konstantina Kolonia, et al. (+9)
17 [GO] 2021―Apr―20 Safety of COVID-19 vaccines administered in the EU: Should we be concerned? Antonio F. Hernández, Daniela Calina, Konstantinos Poulas, Anca Oana Docea, Aristidis M. Tsatsakis
18 [GO] 2021―Mrz―11 COVID-19 pandemic and alcohol consumption: impacts and interconnections Daniela Calina, Thomas Hartung, Ileana Mardare, Mihaela Mitroi, Konstantinos Poulas, Aristidis Tsatsakis, et al. (+2)
19 [GO] 2021―Mrz―10 Use of ivermectin in the treatment of Covid-19: A pilot trial Henrique Pott-Junior, Mônica Maria Bastos Paoliello, Alice de Queiroz Constantino Miguel, Anderson Ferreira da Cunha, Caio Cesar de Melo Freire, Fábio Fernandes Neves, et al. (+4)
20 [GO] 2020―Dez―19 Nicotinic Cholinergic System and COVID-19: In Silico Evaluation of Nicotinic Acetylcholine Receptor Agonists as Potential Therapeutic Interventions Nikolaos Alexandris, George Lagoumintzis, Christos T. Chasapis, Demetres D. Leonidas, Georgios E. Papadopoulos, Socrates J. Tzartos, et al. (+4)
21 [GO] 2020―Dez―03 Improved strategies to counter the COVID-19 pandemic: Lockdowns vs. Primary and Community Healthcare Konstantinos Farsalinos, Konstantinos Poulas, Dimitrios Kouretas, Apostolos Vantarakis, Michalis Leotsinidis, Dimitrios Kouvelas, et al. (+18)
22 [GO] 2020―Aug―31 The role of carbon monoxide and heme oxygenase-1 in COVID-19 Kenneth K. Kwong, Suk-tak Chan
23 [GO] 2020―Jun―18 Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention Aikaterini Nasi, Stephanie McArdle, Gustav Gaudernack, Gabriel Westman, Cornelis Melief, Demetrios Kouretas, et al. (+3)
24 [GO] 2020―Apr―30 Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system Konstantinos Farsalinos, Raymond Niaura, Jacques Le Houezec, Anastasia Barbouni, Aristidis Tsatsakis, Dimitrios Kouretas, et al. (+2)
 [1] 

24 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec